IDEXX Laboratories, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $263.1M | $222.0M | $192.1M | $181.9M | $187.8M | $178.3M | $161.8M | $141.3M |
| Depreciation & Amortization | $83.1M | $78.2M | $69.0M | $58.9M | $54.6M | $52.4M | $48.2M | $46.0M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $9.0M | $9.5M | $10.4M | $9.8M | $9.7M | $9.8M | $8.7M | $9.0M |
| Stock-Based Compensation | $23.5M | $19.9M | $19.9M | $18.1M | $16.5M | $16.0M | $15.5M | $13.3M |
| Net Cash from Operating Activities | $373.3M | $338.9M | $221.8M | $235.8M | $246.0M | $222.4M | $217.9M | $178.8M |
| Investing Activities | ||||||||
| Capital Expenditures | $74.4M | $64.8M | $82.9M | $60.5M | $77.6M | $57.6M | $49.7M | $38.9M |
| Business Acquisitions | $14.6M | $2.0M | $10.3M | $25.1M | $10.9M | $2.7M | $46.8M | — |
| Net Cash from Investing Activities | $-138.7M | — | — | $-80.4M | $-86.1M | $-58.1M | $-94.2M | $-43.2M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $282.6M | $304.1M | $402.0M | $618.2M | $367.8M | $132.3M | $255.5M | $143.1M |
| Net Cash from Financing Activities | $-208.0M | — | — | $-103.4M | $-102.5M | $-125.3M | $-97.7M | $-86.8M |
| Net Change in Cash | $32.8M | $25.9M | $-193.5M | $43.5M | $55.1M | $40.1M | $27.0M | $50.2M |
| Free Cash Flow | $298.9M | $274.2M | $138.9M | $175.3M | $168.4M | $164.8M | $168.2M | $139.9M |